Clinical Trial

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

Study acronym: RADAR
Suspended Phase 3
View on ClinicalTrials.gov →
Why the trial stopped
Study enrollment and treatment are temporarily suspended due to an FDA clinical hold. The sponsor is actively addressing the FDA's requests.
Summary
To obtain an assessment of the efficacy and safety of renal denervation by dehydrated alcohol injection, USP administered via the Peregrine System™ Infusion Catheter in hypertensive subjects in the absence of antihypertensive medications.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-17; most recent amendment 2026-04-27.
Status change: Recruiting → Suspended 2026-04-27
Status change: Not Yet Recruiting → Recruiting 2025-09-10
Trial Details
NCT Number NCT07083765
Lead Sponsor Ablative Solutions, Inc.
Conditions Hypertension, Hypertension,Essential
Enrollment 142 participants
Start Date 2025-09-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-30